Patents for C12R 1 - Micro-organisms (92,025)
02/2003
02/19/2003EP1283888A2 Fructosyltransferases (inulosucrase and levansucrase) from lactobacillus reuteri
02/19/2003EP1283876A2 Beta-galactosidase isolated from bifidobacterium
02/19/2003EP1283875A1 Improved nucleic acid modifying enzymes
02/19/2003EP1283868A2 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
02/19/2003EP1283718A2 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
02/19/2003EP1283676A2 A bioinsecticide formulation consisting of bacillus thuringiensis var israelensis, and its concerning manufacture proceedings
02/19/2003EP1283670A2 Microinjection of cryoprotectants for preservation of cells
02/19/2003EP0795024B1 Enantioselective preparation of pharmaceutically active sulfoxides by biooxidation
02/19/2003EP0758381B1 Biologically active eph family ligands
02/19/2003CN1398299A BZIP type transcripton factors regulating expression of rice storage protein
02/18/2003US6521751 Recombinant nucleic acid sequences and methods for determining both genotoxicity and mutagenicity of a sample and the kinetics of the genotoxicity
02/18/2003US6521746 Leukotoxin polypeptide fused to gonadotropin releasing hormone/factor multimer; increased immunogenicity
02/18/2003US6521450 Cells expressing a modified regulator of complement activation
02/18/2003US6521443 Dairy products without yeast off-flavor; odorless
02/18/2003US6521442 Polynucleotide compositions encoding broad spectrum δ-endotoxins
02/18/2003US6521441 Staphylococcus aureus genes and polypeptides
02/18/2003US6521429 Polyhydroxyalkanoates and method of producing them by utilizing microorganisms
02/18/2003US6521413 Bioassay; monitoring cells for changes in ion channel activity
02/18/2003US6521404 Gene expression of library bacteriophage particles with very light domain antibodies and synthetic very heavy antibodies displayed on surface
02/18/2003US6521403 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
02/18/2003US6521272 High leavening ability; culture of Saccharomyces cerevisiae yeast
02/18/2003US6521235 Alphavirus RNA replicon systems
02/18/2003US6521230 CD25 binding molecules
02/18/2003CA2075366C Immunologically active peptides or polypeptides from the parvovirus b19
02/18/2003CA2071211C Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products
02/18/2003CA2064331C Vascular endothelial cell growth factor c subunit
02/13/2003WO2003012098A1 Modified yeast showing high secretion productivity of foreign protein and process for producing foreign protein using the yeast
02/13/2003WO2002033110A3 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM
02/13/2003US20030032775 Effector proteins of rapamycin
02/13/2003US20030032588 Glucagon antagonists
02/13/2003US20030032186 Method for stable chromosomal multi-copy integration of genes
02/13/2003US20030032170 Method of proliferating a microorganism capable of degrading a hard-to-degrade organic compound and method of degrading a hard-to-degrade arganic compound
02/13/2003US20030032169 Nucleotide sequences coding polypeptide for use in the treatment of cancer, skin and vision defects
02/13/2003US20030032160 Nucleotide sequences coding protein for use in treatment of cancer, inflammation, arthritis and psoriasis
02/13/2003US20030032153 Novel (R)-2,3-butanediol dehydrogenase, methods for producing same, and methods for producing optically active alcohol using the dehydrogenase
02/13/2003US20030032152 Genetically engineered yeast for use in the generation of lactic acid
02/13/2003US20030032144 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
02/13/2003US20030032100 Genes encoding desulfurization enzymes
02/13/2003US20030032085 An expression cassette comprising a transcriptional initiation region, consisting of a 5' non-coding region regulating the transcription of patched protein, a marker gene, and a transcriptional termination region
02/13/2003US20030031741 A metabolite produced by antibiotic-producing Streptomyces sp. strain NRRL No. B-30145 exhibiting fungacidal activity on Alternaria solani, Botrytis cinerea, Rhizoctonia sp., Sclerotinia sp., and Phytophthora sp.
02/13/2003US20030031664 For therapy of pulmonary embolism, myocardial infarction, thrombosis or stroke
02/13/2003US20030031659 For the treatment or prevention of a gastrointestinal infection caused by a pathogenic bacteria; for reducing insect and parasite populations in animal manure
02/13/2003US20030031654 Prohormone convertase transformed cells and polypeptide synthesis
02/12/2003EP1283264A2 Interleukin-3 (IL-3) mutant polypeptides
02/12/2003EP1283259A1 Chondroitin polymerase and DNA encoding the same
02/12/2003EP1283212A1 Methods for identifying compounds that bind to a target
02/12/2003EP1282719A1 Process for the preparation of dihydroxy esters and derivatives thereof
02/12/2003EP1282692A2 Sentinel virus ii
02/12/2003EP1282687A1 Microorganisms for treatment or prevention of obesity and diabetes mellitus, and pharmaceutical composition containing the same
02/12/2003EP1282626A2 Polyketide derivatives
02/12/2003EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis
02/12/2003EP0865447B1 Cyclic dodecapeptide and process for the preparation thereof
02/12/2003EP0728147B1 Receptor specific atrial natriuretic peptides
02/12/2003EP0694068B1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs
02/12/2003CN1396952A Bacteriolytic complex, method for producing said complex and strain for carrying out said method
02/12/2003CN1101469C Genes encoding enzymers of BalI restruction-modification system
02/11/2003US6518316 Cytokine production and tyrosine kinase inhibitors
02/11/2003US6518063 Osf2/Cbfa1 nucleic acids and methods of use therefor
02/11/2003US6518062 Enzyme combinations for destroying proliferative cells
02/11/2003US6518050 Distillation residues of fermentation products and in particular, a process for producing compounds of economic interest from these distillation residues of fermentation products. This production process also comprises suitable
02/11/2003US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of
02/11/2003US6518039 Such as 7-ADCA (3-methyl-4-carboxy-7-amino-3-cephem), via production of the 7-acylated counterparts
02/11/2003US6517845 Detecting infection in a mammal; binding antibody to polypeptide consisting essentially of amino acid sequence 2
02/11/2003CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof
02/11/2003CA2170509C Dna encoding prostaglandin receptor ep2
02/11/2003CA2133843C Melanocyte stimulating hormone receptor and uses
02/11/2003CA2078689C Chimeric antibodies with receptor binding ligands in place of their constant region
02/11/2003CA2068871C Non-glycosylated fgf-4 and compositions containing the same
02/11/2003CA2005704C Pneumolysin mutants and pneumococcal vaccines made therefrom
02/11/2003CA1341419C Process for the introduction of expressible genes into plant cell genomes and agrobacterium strains carrying hybrid ti plasmid vectors useful for this process
02/06/2003WO2003010325A1 Process of producing mannitol and homopolysaccharides
02/06/2003WO2003010298A1 'probiotic lactobacillus salivarius strains
02/06/2003WO2003010297A1 Probiotic bifidobacterium strains
02/06/2003WO2003010194A2 Meningococcus adhesins nada, app and orf 40
02/06/2003WO2003010185A2 Method for making acylated polypeptides
02/06/2003WO2003009858A1 Fermentation medium and method
02/06/2003WO2002059613A3 Oomycete ftsz-mt as a target for antimicrobial-specific biocides
02/06/2003WO2002024879A3 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203
02/06/2003WO2002020815A3 Production of cyclic terpenoids
02/06/2003WO2001004335A8 Human-bovine chimeric respiratory syncytial virus vaccines
02/06/2003US20030028923 Nucleotide sequences coding enzymatic polypeptide for use in the generation of disease resistant plants
02/06/2003US20030027987 Novel polypeptide from Haemophilus paragallinarum and process for preparing the same
02/06/2003US20030027774 For diagnosis and therapy of tuberculosis
02/06/2003US20030027337 Sequence-specific DNA recombination in eukaryotic cells
02/06/2003US20030027317 Enzymatic polypeptide for use as tool in the treatment of viral diseases
02/06/2003US20030027309 Genes of purine biosynthesis from ashbya gossypii and the use thereof in microbial riboflavin synthesis
02/06/2003US20030027297 19 human secreted proteins
02/06/2003US20030027292 Metabolic controlled fermentation process for pseudomonic acid production
02/06/2003US20030027287 Recombinant oleandolide polyketide synthase
02/06/2003US20030027283 Protein l and hybrid proteins thereof
02/06/2003US20030027177 Human DNA mismatch repair proteins
02/06/2003CA2455722A1 Fermentation medium and method
02/06/2003CA2455550A1 Process of producing mannitol and homopolysaccharides
02/06/2003CA2454803A1 Probiotic bifidobacterium strains
02/05/2003EP1281770A2 Human brain phosphodiesterase and screening method
02/05/2003EP1281766A2 Process for producing polyester, process for producing substituted alpha-hydroxy acid, and Clostridium beijerinckii strain HICA432
02/05/2003EP1281765A1 Antisense type gene trap vector
02/05/2003EP1281762A2 Luciferases
02/05/2003EP1281752A1 Spray-dried microbial cells
02/05/2003EP1281702A2 Calcium receptor active molecules